In an attempt to improve the standards of primary respiratory care in the UK,
Background
Against a global background of rising healthcare demands and constrained healthcare funding, it is imperative that the quality of healthcare provision is not diluted. In the UK the provision of highquality medical care has become a pivotal part of government health policy via the Quality, Improvement, Productivity and Prevention (QIPP) agenda 1 and the National Health Service (NHS) Outcomes Framework 2010. 2 The Department of Health (DH) Outcomes Strategy for People with COPD and Asthma 3 and its companion document 4 outline the aspirations for high-quality care in chronic obstructive pulmonary disease (COPD) and asthma. There is, however, evidence of suboptimal care including substantial variation in standards in COPD care across England, 5 variation in the quality of primary care spirometry, 6 and deficiencies in the assessment of the acute asthma attack.
The Quality Standards were initially developed by a multidisciplinary Module Development Group (see Appendix 2, available online at www.thepcrj.org). This group drew upon national respiratory guidelines to produce an initial set of standards and evidence requirements. 3, [8] [9] [10] [11] [12] [13] This initial set was modified by a larger group using the following criteria: whether the standards were truly evidence-based; were practical and deliverable; were generalisable across a UK primary care population; and whether they were evaluable. The number of items of evidence was further reduced after consultation with seven primary care practices varying in size, geography, and socio-economics across the spectrum of UK general practice using the same criteria.
Design and scope of the Award
The Award has been partly based on the generic Royal College of General Practitioners Quality Practice Award (QPA) 14 which assesses quality of care across a wide range of disease areas managed in general practice. QPA involves submission of a written portfolio of evidence across several modules, concentrating mainly on practice organisation.
The PCRS-UK Award is divided into three modules: 'Clinical', 'Organisation', and 'The Practice Team'. These are subdivided into seven standards as shown in Box 2.
The clinical standards are mainly centred on the disease areas of asthma and COPD, but examples of good practice in other areas of respiratory medicine can be submitted. The format of the standards has been modelled on that used by Health Improvement Scotland in their Asthma and COPD Services Clinical Standards. 12, 13 Each standard has a headline statement (e.g. "People listed on the asthma and COPD registers are offered regular structured review of their condition"), followed by the rationale for the statement and finally the evidence required to meet that standard. The full quality standards are shown in Figure 1 .
Practices are asked to submit 37 pieces of written evidence within a 6-month period to the PCRS-UK assessors comprising audits, protocols, significant event analyses, patient case histories, and examples of reflective learning. Assessment of the written portfolio is carried out by two trained independent assessors drawn from the stakeholder organisations. A practice is required to provide all the evidence that it meets these standards in order to gain the PCRS-UK Quality Award.
Piloting of the Award
The Award was initially piloted in 2011 in five respiratory-interested practices in England and Scotland to establish whether working for the Award was feasible and to iron out any practical problems. All phase 1 pilot practices successfully gained the Award. The practices reported that working for the Award had led to numerous improvements in practice organisation, varying from updating outdated protocols to actively involving all members of the practice team rather than respiratory care being carried out by one or two individuals.
As a result of the audit, there were significant improvements in some practices in the quality of spirometry, increased influenza vaccination uptake, and improved review of patients after hospital admission for acute COPD and asthma. The improvements were largely confined to process outcomes such as improved quality of care rather than outcome measures such as reduction in hospital admissions and exacerbations which were not recorded in this pilot phase. However, examples of tangible benefits from patients included improved access to surgery appointments for school children with asthma and improved access to smoking cessation services.
We also analysed qualitative feedback from these practices. Although practices acknowledged the need for extra time to complete the Award, feedback has been positive with comments such as "It has given us the opportunity to take time to really look at our respiratory service in detail … and we're doing a good job" and "It was a motivating process and helped us engage the whole team".
The experience and feedback of the five pilot practices demonstrated that the PCRS-UK Quality Award is an important developmental opportunity for the whole practice and does drive improvements in care, even in high performing practices.
Following this initial pilot phase, minor adjustments to the original evidence requirements (such as examples of patient feedback questionnaires, suggested surveys and audits, and a more detailed practice profile) were made to the Award, which is being tested further in pilot phase 2.
Discussion
Improvement in the quality of provision of healthcare has been a major priority in the UK and many healthcare systems throughout the world. The development and implementation of a Quality Award was seen by the stakeholder organisations as a method of incorporating the key elements of quality care improvement using Wagner's Chronic Care Model 15 (improved organisation, improved health professional clinical care using education, and peer review) into a quality improvement method award that would be achievable in a wide range of primary care practices and raise standards of care.
To set out the standards that best define high quality respiratory care in primary care, providing:
• Recognition of practices delivering a high standard of respiratory care
• A quality assurance mark for patients, commissioning groups and the wider NHS
• A developmental framework that can be used at practice, locality and national levels to promote, support and reward quality respiratory care in the primary care setting 
Rationale
Smoking is known to be a major cause of respiratory illness -COPD, 1, 2 lung cancer, 1, 2 asthma. 1, 3 Smoking cessation advice to all patient groups offered in primary care is an effective intervention in helping smokers to quit. Vaccination programmes to prevent respiratory infection in vulnerable groups offer effective protection against respiratory infection and prevention of complications. 4 All practices participating in the PCRS-UK Quality Award will be able to demonstrate appropriate activity surrounding the process of smoking prevention, smoking cessation and vaccination programmes.
Evidence required to support application (2 parts, both must be completed) Evidence Smoking prevention and cessation
1
The practice must be able to demonstrate a robust smoking cessation policy utilised in the practice which, at a minimum:
• asks all patients who are smokers if they are ready to quit
• ensures those patients expressing an interest in quitting are referred to an appropriate smoking cessation service. • Provide a reflective narrative on what it has learned about the success, or otherwise, of its policy for smoking cessation and any changes the practice has made/intends to make as a result of the survey.
Evidence

Vaccination
3a
The practice will submit the results of its most recent influenza vaccination data and be able to demonstrate that it can achieve its immmunisation targets for influenza vaccination in all vulnerable groups according to local/regional or national standards 3b The practice will reflect on the success of its immunisation rates, how these can be improved and what actions will be taken if it has failed to achieve the desired target influenza vaccination standards 
References
Rationale
There is significant under-diagnosis of COPD in the community and practices should be able to demonstrate that they provide COPD screening at suitable opportunities. Early and accurate diagnosis of respiratory disease is vital for appropriate and successful interventions.
The ability to investigate appropriately and interpret the information leads to accurate diagnoses and relevant successful treatments. Practices will be able to provide evidence, reflecting current national guidance, on how asthma and COPD are diagnosed. Evidence of spirometry should demonstrate that it meets current diagnostic standards and interpretation of spirometry should be in keeping with ATS/ERS standards.
Evidence required to support application (2 parts, both must be completed) Evidence Case finding 4 The practice will describe (maximum one side A4) the systems available for case finding in COPD and a reflective paragraph on the successes/challenges of case finding in COPD.
Evidence Diagnosis 5a (asthma) i. The practice will provide its policy for the diagnosis of asthma and COPD and include evidence 5b (COPD) of the appropriate use of spirometry in the diagnostic process.
6a ii. The practice will demonstrate that its diagnosis policy is effective by providing an example of a patient journey or case study on the diagnosis of asthma
iii. The practice must include a reflective narrative including an action plan for maintaining or improving the standards of diagnosis of respiratory conditions in the practice including identification of misdiagnosed or undiagnosed patients 1 7 iv. The practice will provide an audit of its spirometry practice using the audit template provided (see page 32) including reflection and action plan. Practices should be able to demonstrate that 90% of patients diagnosed with COPD have had their diagnosis confirmed by spirometry (with legitimate exceptions taken into account -details must be provided). An electronic version of this audit is available which provides an automated report of the results of the audit against the audit criteria shown on page 9 and allows practices to compare their own results with other practices. To access the online audit facility please contact the award administrator for a username and password (tricia@pcrs-uk.org). The electronic audit can be accessed at http://www.guideline-audit.com/pcrsuk_copd_dx/instructions.php and includes detailed instructions.
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Proactive structured review for asthma and COPD is associated with an improvement in clinical outcomes such as reduced exacerbation rates, reduced hospitalisations and improved symptom control.
A structured review offers the opportunity to: a) Assess the impact of the disease, identify any co-morbidities and review therapeutic interventions upon the patient.
b) Review and adjust pharmacological and non-pharmacological therapy including the need for specialist respiratory referral.
c) Promote patient self-management and empowerment. Practices will demonstrate how they proactively review their patients with stable asthma and COPD. Practices will demonstrate (in asthma and COPD) the process by which they identify patients at high risk of significant disease impact.
Evidence required to support application (2 parts, all must be completed) Evidence Identification of high-risk patients 8a (asthma) 1. The practice will provide evidence of the frequency of review of patients with asthma and 8b (COPD) COPD (for low-and high-risk patients) in accordance with national guidance by submitting copies of asthma and COPD templates (or other data recording systems) and include a reflective paragraph on the appropriateness/ completeness of the data recording systems. 9 2. The practice will outline the process for identifying high-risk patients and evidence of the systems in place to manage these patients (e.g. protocol) and reflect on the effectiveness of these processes. If the practice does not have a process for identifying high-risk patients they should include reflective narrative including an action plan on how they plan to address this which includes information on how a locum GP, who does not know your patients, would be able to identify high-risk patients. 10 3. The practice will provide evidence of audit (either COPD or asthma) including a reflective narrative and action plan which considers the adequacy and appropriateness of the identification and management policies of high risk patients.
Evidence
Regular review
11a (asthma) 1. The practice will provide copies of its protocol(s) for the management of asthma AND COPD.
11b (COPD) 2. The practice will provide evidence of patient action plans or self-management plans for both 12a (asthma) asthma AND COPD, including a description of educational materials used.
12b (COPD) 3. The practice will provide evidence of how disease is effectively managed, including the regular 13 checking of inhaler device technique. Practices will be able to demonstrate evidence that local/national guidance is implemented. Mechanisms by which the practice can demonstrate this must include at least one audit on asthma or COPD including a reflective paragraph showing evidence of your action plan to address any issues raised in the audit 14 4. Using data in 1-3 above, evaluate how regular review is undertaken in the practice (maximum one A4 sheet of paper)
Further information
National The PCRS-UK has a wide range of tools and resources ranging from nurse patient group directions, nurse protocols and checklists, a series of well respected PCRS-UK opinion sheets and other supported materials. You can access all these materials via the resources menu of the website and using our search resources feature option located in the top right of all PCRS-UK web pages.
Module A: Clinical Care -Acute respiratory care
Standard 4 Practices can demonstrate an effective system for the recognition, assessment and immediate management of patients with acute respiratory problems
Rationale
Patients with respiratory disorders can often present to primary care centres when in crisis. It is essential practice to have systems in place to recognise, assess and manage acute respiratory problems promptly. By having protocols, systems and equipment in place to deal with acute respiratory problems, the practice will be able to deliver prompt, safe and effective management of patients. These protocols should link all team members -from reception staff to doctors -to recognise respiratory distress early. The practice will submit evidence to demonstrate safe, effective and appropriate systems for the identification and management of acute respiratory conditions (including adult and child anaphylaxis) in accordance with national guidance. 
Evidence required to support application
Rationale
Patients with respiratory conditions such as asthma and COPD present to clinicians in primary care. The ability to establish or exclude a diagnosis, to review and treat such patients within a primary care setting is a mark of a quality service and requires the appropriate equipment to be in place, in good working condition and used by appropriately trained staff.
Practices participating in the Award will be required to submit details of the key components of an effective equipment policy including: a) Identifying equipment necessary to meet the needs of clinicians and patients within the frame work of other local services. The practice works in an effective comprehensive multidisciplinary way to meet the needs of patients with respiratory conditions. The practice supports its staff to fulfil their role, and works across organisational boundaries for the benefit of patients and staff.
It is a widely understood concept that united we stand and divided we fall. An effective respiratory team communicates well, listens to each other, works together as a cohesive group for a common objective, learns from and offers support to each other.
In this Award the practice will submit evidence of multidisciplinary leadership (to include a named GP and nurse) which demonstrates how the system of care within and without the practice is led and will also submit evidence of clinical leadership within the practice which demonstrates how that leadership impacts on the practice team. The practice will also submit evidence of how it engages with multidisciplinary teams in the coordination and management of patients with complex respiratory needs. The practice will be able to demonstrate that it can meet the needs of the practice population with respiratory conditions including any patient involvement.
Key components of an effective approach to teamwork are:
• Identifying a clinical lead with responsibility for respiratory care within the practice • A practice training plan based on the needs of both patients and staff, reflecting the particular challenges and working practices of the practice and area Provide an example of where practice has changed through teamwork. For example, consider how you responded to a change in respiratory national guidance (maximum length one side A4).
Further information
The document aims to outline the standards and skills required from the individual primary care nurse to deliver effective respiratory care in primary care with helpful guides for three levels of experience: minimum, medium and maximum. 
Evidence
Patient experience/involvement 20 1. The practice will undertake a survey of a random sample of at least 20 patients with respiratory disease using the template provided (see Appendix 6) . The practice will provide a reflective paragraph on the outcome of the results of the questionnaire and provide an action plan.
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Although quality awards have been used to improve healthcare for several years, the evidence base for their efficacy is not large. The European Foundation for Quality Management 16 has devised a model of healthcare quality improvement and Quality Award which has been adopted by many healthcare organisations in the Netherlands and Germany. However, a systematic review of performance based on this model showed only weak evidence of improvements.
17 Surprisingly, there has only been limited evaluation of the UK Royal College of General Practitioners QPA which mainly focused on general practice organisation. 4 A postal questionnaire sent to practices that had completed the QPA stated that there was an improvement in practice teamwork. 18 In view of this limited evidence, it is important that this Respiratory Practice Award is properly evaluated when it is rolled out beyond the pilot stage.
The development of the PCRS-UK Quality Award involved the successful co-operation of respiratory-interested multi-professional and patient groups. During the iterative process the initial number of pieces of evidence required was reduced to minimise practice workload, and an important section added to include patient experience and practice feedback.
The feedback from the pilot practices suggested that there was a significant amount of work involved in collating the evidence needed for the Award. However, the impact of this increased workload could be greatly reduced by sharing the evidence submission with other members of the primary healthcare team. In return, there were tangible gains with regard to improved teamwork, patient access, and raised process standards (see "Piloting of the Award" section). This should be tempered by the fact that the pilot 1 practices were already respiratory-interested organisations. In addition, questions remain about long-term sustainability of the Award -for example, will improvements be maintained if key personnel leave the practice and will short-term process improvements translate into longer-term outcome benefits such as reduced patient admissions or improved patient quality of life?
It is planned to make the fully functional PCRS-UK Quality Award available to all general practices in the UK in 2013. As the Award is rolled out to a wider range of practices, there is a need to train more assessors. This is being met by training both lay and health professional assessors. A major challenge will be to encourage practices to apply for the Award. One possibility is to encourage groups of practices (e.g. Clinical Commissioning Groups in England) to apply for the Award to meet the UK Government's QIPP agenda using national or local financial incentives. Another possibility is to make individual modules available either as a precursor to carrying out the whole Award or as a quality improvement tool in its own right. Although developed for the UK, the standards would fit with most developed healthcare systems that rely on primary care for the diagnosis, treatment, and management of long-term conditions. It is acknowledged that some of the individual pieces of evidence might need to be changed to reflect local practice, although significant event analyses, reflection The practice will demonstrate evidence of a mechanism to show that there is appropriate significant event analyses relating to care for people with respiratory conditions when they occur. These may be linked to palliative care, hospital admissions, late diagnoses. The practice will provide evidence of a strategy to ensure appropriate, relevant and ongoing training and professional development for all those involved in respiratory care, ensuring that all aspects of disease management are covered within the practice including competency to perform and interpret necessary diagnostic testing, e.g. spirometry.
Evidence required to support application (3 parts, all must be completed) Evidence
Development/learning plan
21
The practice has a current practice development plan, updated in the last 12 months, and educational activity record which provides information on training and education requirements, continuing professional development and the dissemination of relevant and appropriate guidance for the management of respiratory conditions. The practice will complete the education planForm PCD1 (see
Appendix 14)
Further information
Revalidation Guidelines for GP's . • How is risk assessment covered in the education plan e.g. lifting and carrying, resuscitation, arranging cover for colleagues or during holiday periods etc?
• How is equipment-specific training dealt with and achieved to a satisfactory level?
24 ii. The practice will provide a document (maximum two pages A4) which outlines the learning experiences of participating in this Quality Award including the following:-
• What work did the team need to implement in order to participate in the Award?
• What were the learning experiences of the Award for the practice team?
• What new processes, actions will the practice be introducing as a result of participating in this Award?
• What, if any, training requirements have been identified as a result of participating in this Award?
• What have been the benefits to the practice of participating in this Award?
on multidisciplinary working, and completed audits are universally applicable.
Conclusions
The PCRS-UK Quality Award has been developed in conjunction with major professional and patient respiratory organisations in the UK. It offers a possible tool to provide a developmental framework that can be used at the practice, locality, and national level to promote high-quality respiratory medicine in primary care. Further details of the Award can be found on the PCRS-UK website (http://www.pcrs-uk.org/pcrs-uk-quality-award).
Handling editor Mike Thomas
Acknowledgements In addition to all the work of the development committees, we would like to thank Inez Gentiles and Anne Smith for their hard work and commitment to this project. Contributorship Kevin Gruffydd-Jones is the principal author of this article , with significant contributions regarding methodology and input into the discussion from the other authors.
Conflicts of interest
